Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
Authors
Keywords
Prostate cancer, Biomarkers, Radical prostatectomy, Cancer treatment, Nuclear staining, Death rates, Surgical and invasive medical procedures, Surgical oncology
Journal
PLoS One
Volume 10, Issue 7, Pages e0132343
Publisher
Public Library of Science (PLoS)
Online
2015-07-15
DOI
10.1371/journal.pone.0132343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer
- (2015) Stéphane Terry et al. CANCER
- Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
- (2015) G. Attard et al. CLINICAL CANCER RESEARCH
- Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
- (2015) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- SPINK1 Protein Expression and Prostate Cancer Progression
- (2014) R. Flavin et al. CLINICAL CANCER RESEARCH
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- ERG Protein Expression in Diagnostic Specimens Is Associated with Increased Risk of Progression During Active Surveillance for Prostate Cancer
- (2014) Kasper Drimer Berg et al. EUROPEAN UROLOGY
- Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
- (2014) Samir Al Bashir et al. Journal of Hematology & Oncology
- Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
- (2014) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologic differences between peripheral and transition zone prostate cancer
- (2014) J. Joy Lee et al. PROSTATE
- Managing localized prostate cancer in the era of prostate-specific antigen screening
- (2013) James D. Brooks CANCER
- Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
- (2013) K. A. Leinonen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
- (2013) D. W. Lin et al. CLINICAL CANCER RESEARCH
- The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature
- (2013) Bin Xu et al. HUMAN PATHOLOGY
- Prostate Cancer Risk Profiles of Asian-American Men: Disentangling the Effects of Immigration Status and Race/Ethnicity
- (2013) Daphne Y. Lichtensztajn et al. JOURNAL OF UROLOGY
- Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study
- (2013) Sheila Weinmann et al. PROSTATE
- A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers
- (2012) Sarah Hawley et al. ADVANCES IN ANATOMIC PATHOLOGY
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
- (2012) A. Pettersson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Combined analysis ofTMPRSS2-ERGandTERTfor improved prognosis of biochemical recurrence in prostate cancer
- (2012) Rasa Sabaliauskaite et al. GENES CHROMOSOMES & CANCER
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
- (2012) Alcides Chaux et al. MODERN PATHOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
- (2011) Alcides Chaux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Therapeutic Targeting of SPINK1-Positive Prostate Cancer
- (2011) B. Ateeq et al. Science Translational Medicine
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- The Ability of Biomarkers to Predict Systemic Progression in Men with High-Risk Prostate Cancer Treated Surgically Is Dependent on ERG Status
- (2010) R. J. Karnes et al. CANCER RESEARCH
- Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
- (2010) K. A. Leinonen et al. CLINICAL CANCER RESEARCH
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
- (2009) K. G. Hermans et al. CLINICAL CANCER RESEARCH
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
- (2009) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- Prostate cancer of transition zone origin lacks TMPRSS2–ERG gene fusion
- (2009) Charles C Guo et al. MODERN PATHOLOGY
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of TMPRSS2-ERG Fusion Gene Expression in Prostate Cancer Specimens by a Novel Assay Using Branched DNA
- (2009) Bin Lu et al. UROLOGY
- Integration ofERGgene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
- (2008) Sameer Jhavar et al. BJU INTERNATIONAL
- The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers
- (2008) Scott A. Tomlins et al. CANCER CELL
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
- (2008) Martin G. Sanda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of prostate cancer originating from the transition zone
- (2008) Christopher R. King et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search